VC Catalog · venture ecosystem research library
VC Catalog home Beta

Company

Multivalent Biotherapies

Rocket Ship RatingBased on the data VC Catalog holds.

Rocket Ship Rating: 89 out of 100

Targeted Therapy for Prostate Cancer

Also known as MultiValent Biotherapies, Inc

  • Biotech & therapeutics
Status
Operatingas of 2026-09-17
Legal name
MultiValent Biotherapies, Inc
Open relationship map
Claim, correct or request removal

Record updated 29 September 2026

About

Developing an innovative treatment for prostate cancer to preserve quality of life and long-term health.

Funding snapshot

Total raised
$10MSEC form D sum, as of 2026-09-29Source (opens in a new tab)
Latest round
Round, $10M2026-01-09

Funding rounds

Round, 2026
$10M2026-01-09, SEC form D sold, 4 investors
Round, 2026
$4.4K2026-01-05, SEC form D sold, 11 investors
Loading relationship preview

Cookies on VC Catalog

We use necessary cookies to run the site (sign-in, security, remembering this choice). With your permission we also use Google Analytics to understand how the site is used. Analytics cookies are set only if you accept all cookies. Privacy policy